[核医学]
Asian International Session1
2021年11月4日(木) 09:00 〜 10:00 第9会場 (2号館2階 会議室223)
座長:中條 正豊(鹿児島大学大学院 医歯学総合研究科 放射線診断治療学分野)、 森田 敬裕(国立がん研究センター東病院 放射線診断科)
共催:チャートウェルヘルスケア株式会社
Hong Hua Piao1、 Subin Jeon1、 Su Woong Yoo1、 Young Jae Ryu2,4、 Dong-Yeon Kim3、 Ayoung Pyo1、 Hee-Seung Bom1,4、 Jung-Joon Min1,4、 Seong Young Kwon1,4 * (1.Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, Jeonnam, 58128, Republic of Korea、 2.Department of Surgery, Chonnam National University Hwasun Hospital, Jeonnam, 58128, Republic of Korea、 3.College of Pharmacy and Research Institute of Pharmaceutical Science, Gyeongsang National University, Jinju, 52828, Republic of Korea、 4.Department of Nuclear Medicine, Chonnam National University Medical School, Jeonnam, 58128, Republic of Korea)
Khairul Azreen bin Mohd Sabri、 Muhammad Zulfadzli Bin Ismail、 Singning Yeoh、 Hamidah Lau、 Teckhuat Wong (Department of Nuclear Medicine, Sarawak General Hospital, Malaysia)
Jie Ding1、 Anli Tong2、 Yushi Zhang3、 Jin Wen3、 Hui Zhang4、 Marcus Hacker5、 Li Huo *1、 Xiang Li5 (1.Department of Nuclear Medicine, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Science and PUMC, Beijing, China、 2.Department of Endocrinology and Key Laboratory of Endocrinology, Ministry of Health, PUMC Hospital, Chinese Academy of Medical Science and PUMC, Beijing, China、 3.Department of Urological Surgery, PUMC Hospital, Chinese Academy of Medical Science and PUMC, Beijing, China、 4.Department of pathology, PUMC Hospital, Chinese Academy of Medical Science and PUMC, Beijing, China、 5.Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria)